Bridging the gap between connection and outcome.
Many cross-border partnerships struggle to move beyond introductory discussions. NAPPA exists to ensure promising connections translate into tangible, execution-driven outcomes.
Mission
The North America Pharmaceutical Professional Alliance (NAPPA) is a North America-based, globally connected non-profit organization launched in March 2026 in Boston. We connect biopharma innovators, industry leaders, and capital across the U.S., China, and Asia-Pacific — and we structure ourselves to make those connections produce real, measurable outcomes.
Why NAPPA exists
Cross-border biopharma is full of introductions that never become deals. Conversations stall. Diligence drags. Time zones, capital structures, and regulatory environments add friction at every step. NAPPA was founded by operators who have lived this problem — across BMS, Wyeth, WuXi AppTec, CrownBio, J&J, Eli Lilly, and major investors — and built the organization specifically to remove that friction.
How we're different
Our dual-track model pairs a non-profit platform — for trust, ecosystem, and advisory — with a commercial arm built for the actual execution of complex cross-border projects. We pick up where most alliances stop.
Our reach
- Headquartered in Boston, MA, USA.
- Active partnerships across China (MEDV, Tianjin Health Industry Zone, CNMIA, TONACEA).
- Australian Chapter live; further chapters planned across the SF Bay Area, Taiwan, Singapore, and the UK.